This observation is relevant with respect to drug development since NR4A1 has been implicated as a potential drug target for multiple diseases including cancer and many other inflammatory diseases (Pearen and Muscat, 2010; Kurakula et al., 2014; Zhang et al., 2018; Chen et al., 2020). The gene discussed is NR4A1; the disease is cancer.